A Study to Learn More About Treatment With Damoctocog Alfa Pegol, How it is Used in Every Day Practice ("Real-World"), and How Satisfied People Who Receive Damoctocog Alfa Pegol Are in United States (US) Hemophilia Treatment Centers
Clinical trial NCT05395858 · TERMINATED
Trial details
- NCT number
- NCT05395858
- Sponsor
- Bayer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-17
- Primary completion
- 2023-11-06
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.